Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells.
Ottaiano A, di Palma A, Napolitano M, Pisano C, Pignata S, Tatangelo F, Botti G, Acquaviva AM, Castello G, Ascierto PA, Iaffaioli RV, Scala S. Ottaiano A, et al. Among authors: castello g. Cancer Immunol Immunother. 2005 Aug;54(8):781-91. doi: 10.1007/s00262-004-0636-3. Epub 2004 Dec 11. Cancer Immunol Immunother. 2005. PMID: 15592929 Free PMC article.
Human melanoma metastases express functional CXCR4.
Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G. Scala S, et al. Among authors: castello g. Clin Cancer Res. 2006 Apr 15;12(8):2427-33. doi: 10.1158/1078-0432.CCR-05-1940. Clin Cancer Res. 2006. PMID: 16638848
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S. Ottaiano A, et al. Among authors: castello g. Clin Cancer Res. 2006 May 1;12(9):2795-803. doi: 10.1158/1078-0432.CCR-05-2142. Clin Cancer Res. 2006. PMID: 16675573
CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type.
Scala S, Ieranò C, Ottaiano A, Franco R, La Mura A, Liguori G, Mascolo M, Staibano S, Ascierto PA, Botti G, De Rosa G, Castello G. Scala S, et al. Among authors: castello g. Cancer Immunol Immunother. 2007 Oct;56(10):1589-95. doi: 10.1007/s00262-007-0303-6. Epub 2007 Apr 5. Cancer Immunol Immunother. 2007. PMID: 17410362 Free PMC article.
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.
Ottaiano A, Mollo E, Di Lorenzo G, Pisano C, Di Maio M, Barletta E, Pensabene M, Segati R, Bullian P, Nasti G, Bryce J, Scala S, Castello G, Ascierto PA. Ottaiano A, et al. Among authors: castello g. Cancer Immunol Immunother. 2005 Jan;54(1):44-50. doi: 10.1007/s00262-004-0567-z. Cancer Immunol Immunother. 2005. PMID: 15693138 Free PMC article. Review.
Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A, Leonardi E, Simeone E, Ascierto PA, Scala S, Calemma R, Bryce J, Caracò C, Satriano RA, Gianfranco N, Franco R, Botti G, Castello G. Ottaiano A, et al. Among authors: castello g. Cytokine. 2006 Feb 7;33(3):150-5. doi: 10.1016/j.cyto.2006.01.002. Epub 2006 Mar 6. Cytokine. 2006. PMID: 16517174
220 results